Business

Ethics Approval Received for NUZ-001 Oral Liquid P1 Study

Ethics Approval Received for NUZ-001 Oral Liquid P1 Study

Neurizon Therapeutics LimitedMay 12, 20265
Ethics Approval Received for NUZ-001 Oral Liquid P1 Study

About this update from Neurizon Therapeutics Limited

Neurizon Therapeutics Limited has released a press release. View Attachment

View stock analysis, news, and events for Neurizon Therapeutics Limited

More from Neurizon Therapeutics Limited

All Neurizon Therapeutics Limited news →